APGE Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 36.10%

Insider Buying (Last 12 Months): $990,800.00

Insider Selling (Last 12 Months): $12,378,800.40

Apogee Therapeutics Insider Trading History Chart

Apogee Therapeutics Share Price & Price History

^$38.33

▼ -0.2 (-0.52%)

As of 03/13/2025 05:00 PM ET

Days: 30 | 90 | 365

Apogee Therapeutics Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
3/5/2025	Carl Dambkowski	Insider	Sell	1,590	$30.48	$48,463.20	251,033
3/5/2025	Michael Thomas Henderson	CEO	Sell	10,000	$30.15	$301,500.00	1,292,987
2/5/2025	Carl Dambkowski	Insider	Sell	3,520	$40.69	$143,228.80	252,623
2/5/2025	Michael Thomas Henderson	CEO	Sell	15,000	$40.58	$608,700.00	1,302,987
1/8/2025	Michael Thomas Henderson	CEO	Sell	15,000	$48.85	$732,750.00	1,309,487
1/2/2025	Carl Dambkowski	Insider	Sell	4,085	$46.94	$191,749.90	255,348
12/12/2024	Mark C Mckenna	Director	Buy	20,000	$49.54	$990,800.00	20,000
12/11/2024	Carl Dambkowski	Insider	Sell	4,540	$48.76	$221,370.40	258,073
12/4/2024	Carl Dambkowski	Insider	Sell	6,665	$46.07	$307,056.55	260,798
12/4/2024	Michael Thomas Henderson	CEO	Sell	15,000	$46.58	$698,700.00	1,324,487
11/6/2024	Carl Dambkowski	Insider	Sell	6,665	$59.12	$394,034.80	267,463
11/6/2024	Michael Thomas Henderson	CEO	Sell	15,000	$59.22	$888,300.00	1,339,487
10/2/2024	Carl Dambkowski	Insider	Sell	6,665	$56.26	$374,972.90	274,128
10/2/2024	Michael Thomas Henderson	CEO	Sell	40,000	$56.23	$2,249,200.00	1,354,487
9/4/2024	Carl Dambkowski	Insider	Sell	6,665	$47.56	$316,987.40	280,793
9/4/2024	Michael Thomas Henderson	CEO	Sell	40,000	$47.62	$1,904,800.00	1,394,487
8/23/2024	Jane Henderson	CFO	Sell	6,000	$48.26	$289,560.00	200,871
8/7/2024	Carl Dambkowski	Insider	Sell	7,335	$40.67	$298,314.45	287,458
8/7/2024	Michael Thomas Henderson	CEO	Sell	40,000	$40.62	$1,624,800.00	1,434,487
7/5/2024	Michael Thomas Henderson	CEO	Sell	15,000	$37.26	$558,900.00	1,474,487
7/3/2024	Carl Dambkowski	Insider	Sell	5,995	$37.60	$225,412.00	294,793
7/13/2023	Nimish P Shah	Director	Buy	1,750,000	$17.00	$29,750,000.00	1,750,000

See Full Table

SEC Filings (Institutional Ownership Changes) for Apogee Therapeutics (NASDAQ:APGE)

79.04% of Apogee Therapeutics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Apogee Therapeutics Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
2/28/2025	Universal Beteiligungs und Servicegesellschaft mbH	143,952	$6.52M	0.0%	N/A	0.320%
2/19/2025	GF Fund Management CO. LTD.	945	$43K	0.0%	N/A	0.002%
2/18/2025	Neo Ivy Capital Management	38,523	$1.75M	0.4%	N/A	0.086%
2/17/2025	Voloridge Investment Management LLC	41,106	$1.86M	0.0%	-1.5%	0.091%
2/17/2025	Woodline Partners LP	1,015,608	$46.01M	0.3%	+4.0%	2.255%
2/17/2025	Soleus Capital Management L.P.	70,000	$3.17M	0.2%	N/A	0.155%
2/17/2025	Squarepoint Ops LLC	36,344	$1.65M	0.0%	+90.9%	0.081%
2/17/2025	Two Sigma Advisers LP	71,500	$3.24M	0.0%	+51.5%	0.159%
2/17/2025	Two Sigma Investments LP	266,482	$12.07M	0.0%	+33.7%	0.592%
2/17/2025	Rafferty Asset Management LLC	57,673	$2.61M	0.0%	+5.7%	0.128%
2/17/2025	Point72 Asset Management L.P.	302,735	$13.71M	0.0%	-57.2%	0.672%
2/17/2025	ProShare Advisors LLC	12,805	$0.58M	0.0%	+30.4%	0.028%
2/17/2025	Paradigm Biocapital Advisors LP	1,283,766	$58.16M	2.0%	+82.9%	2.851%
2/17/2025	Parkman Healthcare Partners LLC	85,000	$3.85M	0.5%	N/A	0.189%
2/17/2025	Nuveen Asset Management LLC	137,826	$6.24M	0.0%	+1.8%	0.306%
2/17/2025	Millennium Management LLC	130,171	$5.90M	0.0%	+44.6%	0.289%
2/17/2025	MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.	23,835	$1.08M	0.0%	+4.1%	0.053%
2/17/2025	Janus Henderson Group PLC	1,135,100	$51.46M	0.0%	+141.7%	2.521%
2/17/2025	Jefferies Financial Group Inc.	887,497	$40.20M	0.2%	+140.4%	1.971%
2/17/2025	Granahan Investment Management LLC	92,854	$4.21M	0.2%	+1.2%	0.206%
2/17/2025	Frontier Capital Management Co. LLC	172,711	$7.82M	0.1%	-44.5%	0.384%
2/17/2025	Family Management Corp	7,013	$0.32M	0.1%	-13.2%	0.016%
2/17/2025	D. E. Shaw & Co. Inc.	9,813	$0.45M	0.0%	-80.2%	0.022%
2/17/2025	Deutsche Bank AG	31,739	$1.44M	0.0%	+50.9%	0.070%
2/17/2025	Driehaus Capital Management LLC	2,605,310	$118.02M	1.0%	+2.8%	5.786%
2/17/2025	Cubist Systematic Strategies LLC	91,213	$4.13M	0.0%	+8.6%	0.203%
2/17/2025	Braidwell LP	1,540,362	$69.78M	2.1%	-6.3%	3.421%
2/17/2025	Bank of America Corp DE	105,540	$4.78M	0.0%	-64.8%	0.234%
2/17/2025	BNP Paribas Financial Markets	4,824	$0.22M	0.0%	N/A	0.011%
2/17/2025	Ameriprise Financial Inc.	5,710	$0.26M	0.0%	N/A	0.013%
2/17/2025	Allostery Investments LP	100,000	$4.53M	4.7%	N/A	0.222%
2/14/2025	Boxer Capital Management LLC	86,000	$3.90M	0.3%	N/A	0.191%
2/14/2025	RA Capital Management L.P.	1,569,491	$71.10M	0.9%	-20.0%	3.485%
2/14/2025	Mercer Global Advisors Inc. ADV	720,101	$32.62M	0.1%	N/A	1.599%
2/14/2025	Comerica Bank	20,540	$0.93M	0.0%	-26.8%	0.046%
2/14/2025	Schonfeld Strategic Advisors LLC	70,766	$3.21M	0.0%	N/A	0.157%
2/14/2025	Northern Trust Corp	327,292	$14.83M	0.0%	+6.8%	0.727%
2/14/2025	The Manufacturers Life Insurance Company	87,953	$3.98M	0.0%	+29.4%	0.195%
2/14/2025	Virtus ETF Advisers LLC	1,604	$73K	0.0%	-25.0%	0.004%
2/14/2025	Voya Investment Management LLC	45,960	$2.08M	0.0%	-18.7%	0.102%
2/14/2025	Adage Capital Partners GP L.L.C.	240,200	$10.88M	0.0%	N/A	0.533%
2/14/2025	Price T Rowe Associates Inc. MD	1,052,595	$47.68M	0.0%	+38.8%	2.338%
2/14/2025	Diadema Partners LP	50,620	$2.29M	1.0%	N/A	0.112%
2/14/2025	B Group Inc.	15,000	$0.68M	0.4%	N/A	0.033%
2/14/2025	Tower Research Capital LLC TRC	6,287	$0.29M	0.0%	+356.6%	0.014%
2/14/2025	MetLife Investment Management LLC	22,960	$1.04M	0.0%	+8.7%	0.051%
2/14/2025	Capital World Investors	205,100	$9.29M	0.0%	N/A	0.455%
2/13/2025	Marshall Wace LLP	75,849	$3.44M	0.0%	+1,963.9%	0.168%
2/13/2025	Affinity Asset Advisors LLC	931,728	$42.21M	5.6%	+40.3%	2.069%
2/13/2025	Jump Financial LLC	20,867	$0.95M	0.0%	N/A	0.046%
2/13/2025	XTX Topco Ltd	6,348	$0.29M	0.0%	N/A	0.014%
2/13/2025	Barclays PLC	476,760	$21.60M	0.0%	+30.6%	1.059%
2/13/2025	Optimize Financial Inc	4,473	$0.20M	0.2%	N/A	0.010%
2/13/2025	Kennedy Capital Management LLC	72,307	$3.28M	0.1%	+75.5%	0.161%
2/13/2025	Legal & General Group Plc	25,873	$1.17M	0.0%	+15.7%	0.057%
2/13/2025	Invesco Ltd.	21,256	$0.96M	0.0%	-83.9%	0.047%
2/13/2025	ADAR1 Capital Management LLC	41,274	$1.87M	0.4%	-27.8%	0.092%
2/13/2025	FMR LLC	7,499,382	$339.72M	0.0%	0.0%	16.654%
2/13/2025	Wells Fargo & Company MN	17,705	$0.80M	0.0%	-82.0%	0.039%
2/12/2025	Geode Capital Management LLC	816,113	$36.98M	0.0%	-0.9%	1.812%
2/12/2025	Franklin Resources Inc.	866,188	$39.24M	0.0%	+0.6%	1.924%
2/12/2025	Alliancebernstein L.P.	1,355,185	$61.39M	0.0%	+13.5%	3.010%
2/12/2025	Wellington Management Group LLP	4,517,363	$204.64M	0.0%	-6.2%	10.032%
2/12/2025	JPMorgan Chase & Co.	37,255	$1.69M	0.0%	+26.1%	0.083%
2/11/2025	Corebridge Financial Inc.	18,839	$0.85M	0.0%	-7.0%	0.042%
2/11/2025	Vanguard Group Inc.	2,097,597	$95.02M	0.0%	-1.4%	4.658%
2/11/2025	KLP Kapitalforvaltning AS	5,000	$0.23M	0.0%	N/A	0.011%
2/11/2025	Teacher Retirement System of Texas	6,689	$0.30M	0.0%	+38.2%	0.015%
2/11/2025	Platinum Investment Management Ltd.	95,646	$4.33M	0.3%	-11.2%	0.212%
2/11/2025	Intech Investment Management LLC	16,934	$0.77M	0.0%	+232.0%	0.038%
2/10/2025	Commonwealth Equity Services LLC	4,906	$0.22M	0.0%	N/A	0.011%
2/10/2025	Erste Asset Management GmbH	24,000	$1.10M	0.0%	N/A	0.053%
2/10/2025	Swiss National Bank	44,300	$2.01M	0.0%	+17.5%	0.098%
2/7/2025	Candriam S.C.A.	85,661	$3.88M	0.0%	-4.8%	0.190%
2/6/2025	Arizona State Retirement System	6,517	$0.30M	0.0%	+17.3%	0.014%
2/6/2025	Aigen Investment Management LP	4,767	$0.22M	0.0%	N/A	0.011%
2/6/2025	Victory Capital Management Inc.	223,062	$10.11M	0.0%	-35.6%	0.495%
2/6/2025	Charles Schwab Investment Management Inc.	277,492	$12.57M	0.0%	-1.0%	0.616%
2/4/2025	Bank of New York Mellon Corp	110,827	$5.02M	0.0%	-1.6%	0.246%
2/3/2025	Handelsbanken Fonder AB	7,500	$0.34M	0.0%	-14.8%	0.017%
1/31/2025	New York State Common Retirement Fund	12,187	$0.55M	0.0%	+8.9%	0.027%
1/31/2025	AlphaCentric Advisors LLC	5,649	$0.26M	0.3%	-33.5%	0.013%
1/30/2025	Rhumbline Advisers	52,720	$2.39M	0.0%	+3.4%	0.117%
1/24/2025	China Universal Asset Management Co. Ltd.	9,547	$0.43M	0.0%	+10.3%	0.021%
1/17/2025	SG Americas Securities LLC	9,890	$0.45M	0.0%	+22.2%	0.022%
12/26/2024	JPMorgan Chase & Co.	29,555	$1.74M	0.0%	+4.3%	0.066%
12/19/2024	Principal Financial Group Inc.	3,517	$0.21M	0.0%	-45.4%	0.008%
11/27/2024	Franklin Resources Inc.	860,989	$48.05M	0.0%	-14.4%	1.912%
11/18/2024	Teachers Retirement System of The State of Kentucky	11,644	$0.68M	0.0%	-21.4%	0.026%
11/16/2024	Geode Capital Management LLC	823,839	$48.40M	0.0%	+11.2%	1.830%
11/15/2024	Barclays PLC	365,046	$21.44M	0.0%	+369.2%	0.811%
11/15/2024	Wellington Management Group LLP	4,814,400	$282.80M	0.0%	+35.7%	10.692%
11/15/2024	Wexford Capital LP	3,922	$0.23M	0.1%	N/A	0.009%
11/15/2024	State Street Corp	1,411,639	$82.92M	0.0%	-9.6%	3.135%
11/15/2024	Point72 DIFC Ltd	19,207	$1.13M	0.0%	+14.5%	0.043%
11/15/2024	Point72 Asset Management L.P.	707,268	$41.55M	0.1%	+162.7%	1.571%
11/15/2024	Janus Henderson Group PLC	469,557	$27.59M	0.0%	+4,018.9%	1.043%
11/15/2024	HighVista Strategies LLC	61,788	$3.63M	1.3%	-21.7%	0.137%
11/14/2024	Braidwell LP	1,643,226	$96.52M	2.7%	-31.3%	3.652%
11/14/2024	Vestal Point Capital LP	136,500	$8.02M	0.6%	N/A	0.303%

Data available starting January 2016

See Full Table

Apogee Therapeutics, Inc., through its subsidiary, operates as a biotechnology company that develops biologics for the treatment of atopic dermatitis (AD), asthma, chronic obstructive pulmonary disease (COPD), and related inflammatory and immunology indications. The company primarily develops APG777, a subcutaneous (SQ) extended half-life monoclonal antibody (mAb) for AD; and APG808, an SQ extended half-life mAb for COPD. Its earlier-stage programs comprise APG990, an SQ extended half-life mAb for the treatment of AD; and APG222, an extended half-life SQ antibodies for AD. Apogee Therapeutics, Inc. was incorporated in 2022 and is headquartered in Waltham, Massachusetts.

Today's Range

Now: $38.33

$38.02

$40.03

50 Day Range

MA: $38.55

$30.37

$49.57

52 Week Range

Now: $38.33

$29.10

$71.75

Volume

873,992 shs

Average Volume

494,591 shs

Market Capitalization

$1.73 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

2.46

Who are the company insiders with the largest holdings of Apogee Therapeutics?: Apogee Therapeutics' top insider shareholders include:
Nimish P Shah (Director)
Michael Thomas Henderson (CEO)
Carl Dambkowski (Insider)
Jane Henderson (CFO)
Mark C Mckenna (Director)
Learn More about top insider investors at Apogee Therapeutics.
Who are the major institutional investors of Apogee Therapeutics?: Apogee Therapeutics' top institutional shareholders include:
FMR LLC — 16.65%
Wellington Management Group LLP — 10.03%
Driehaus Capital Management LLC — 5.79%
Vanguard Group Inc. — 4.66%
RA Capital Management L.P. — 3.49%
Braidwell LP — 3.42%
Learn More about top institutional investors of Apogee Therapeutics stock.
Which institutional investors are selling Apogee Therapeutics stock?: During the last quarter, APGE stock was sold by these institutional investors:
Point72 Asset Management L.P.
RA Capital Management L.P.
Wellington Management Group LLP
Bank of America Corp DE
Frontier Capital Management Co. LLC
Victory Capital Management Inc.
Invesco Ltd.
Braidwell LP
Within the previous year, company insiders that have sold Apogee Therapeutics company stock include:
Nimish P Shah (Director)
Michael Thomas Henderson (CEO)
Carl Dambkowski (Insider)
Learn More investors selling Apogee Therapeutics stock.
Which institutional investors are buying Apogee Therapeutics stock?: In the last quarter, APGE stock was bought by institutional investors including:
Mercer Global Advisors Inc. ADV
Janus Henderson Group PLC
Paradigm Biocapital Advisors LP
Jefferies Financial Group Inc.
Price T Rowe Associates Inc. MD
Affinity Asset Advisors LLC
Adage Capital Partners GP L.L.C.
Capital World Investors
Within the previous year, these company insiders have bought Apogee Therapeutics stock:
Nimish P Shah (Director)
Michael Thomas Henderson (CEO)
Learn More investors buying Apogee Therapeutics stock.